- Main
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
- Carroll, Peter R;
- Parsons, J Kellogg;
- Andriole, Gerald;
- Bahnson, Robert R;
- Castle, Erik P;
- Catalona, William J;
- Dahl, Douglas M;
- Davis, John W;
- Epstein, Jonathan I;
- Etzioni, Ruth B;
- Farrington, Thomas;
- Hemstreet, George P;
- Kawachi, Mark H;
- Kim, Simon;
- Lange, Paul H;
- Loughlin, Kevin R;
- Lowrance, William;
- Maroni, Paul;
- Mohler, James;
- Morgan, Todd M;
- Moses, Kelvin A;
- Nadler, Robert B;
- Poch, Michael;
- Scales, Chuck;
- Shaneyfelt, Terrence M;
- Smaldone, Marc C;
- Sonn, Geoffrey;
- Sprenkle, Preston;
- Vickers, Andrew J;
- Wake, Robert;
- Shead, Dorothy A;
- Freedman-Cass, Deborah A
- et al.
Published Web Location
https://doi.org/10.6004/jnccn.2016.0060Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-